BridgeBio Pharma, Inc. (BBIO) Operating income 2017–2025
BridgeBio Pharma, Inc. (BBIO) annual operating income history from SEC filings — each fiscal year as reported.
-$523.4MFY2025 · since FY2017: -$43.9M → -$523.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$523.4M | +11.7% |
| FY2024 | -$593.0M | +2.4% |
| FY2023 | -$607.4M | -18.6% |
| FY2022 | -$512.2M | +11.2% |
| FY2021 | -$576.6M | -21.5% |
| FY2020 | -$474.5M | -78.2% |
| FY2019 | -$266.2M | -45.0% |
| FY2018 | -$183.7M | -318.8% |
| FY2017 | -$43.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice